Skip to content
BidSonarBidSonar

Awarded contract

NHS Type 2 Diabetes Remission Programme - Lincolnshire Wave 4

Lincolnshire-based procurement opportunity to deliver Type 2 Diabetes remission support services as part of NHS Wave 4 programme expansion.

Published 19 Jun 2026 · 5 months agoContracts Finder

View on sourceContracts Finder

Award notice and full record on the publisher's site

Tender closed

31 Mar 2026

7 months ago

Contract value

£234,500

Pounds sterling

Sector

Healthcare & Medical

Browse related listings

Location

United Kingdom

Publisher
UK Cabinet Office
Licence
OGL v3.0
Record ID
ba014d37-b129-4cd8-b73f-0108ced97b64-902797

Suppliers

1 supplier

Lifecycle

Contract awarded. Originally published 5 months ago.

Awarded
  1. Tender deadline31 Mar 202634 weeks ago
  2. Published19 Jun 20265 months ago

Brief

This is a procurement opportunity for NHS Type 2 Diabetes Path to Remission Programme Wave 4, Lot 8, covering services in Lincolnshire. The programme aims to support patients with Type 2 Diabetes through structured interventions designed to achieve remission or improved health outcomes. Suppliers should provide services aligned with NHS standards and the programme's clinical guidelines. This is part of a broader NHS initiative to offer evidence-based diabetes management and lifestyle intervention programmes across multiple regions in Wave 4 of the rollout.

Track record

Open field. No single supplier dominates the field.

127 awards · 90 winners

In this category, NHS ENGLAND has awarded 127 contracts to 90 suppliers.

Who wins here

  1. OVIVA UK LIMITED12× · 9%

+84 more suppliers

Across this category, the most active winners are CARE LINE HOMECARE LIMITED, SPRINGFIELD HOME CARE SERVICES LIMITED, HERTS and ESSEX FERTILITY CENTRE LIMITED — the field to beat, or your route in as a partner.

Ask an assistant

Add BidSonar to the assistant you already use, then ask it about this notice in plain English.

More from NHS ENGLAND

4 listingsView all

NHS Fidaxomicin Supply Framework

NHS ENGLAND

NHS England invites fidaxomicin suppliers to express interest in a national supply framework with anticipated growth in demand.

PlannedHealthcare & MedicalUnited KingdomPublished 17 Nov 2026

est.£22,320,000

Open in Healthcare & Medical

4 open listingsView all